Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
| Status: | Completed |
|---|---|
| Conditions: | Acne, Acne, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 40 |
| Updated: | 6/8/2018 |
| Start Date: | March 13, 2017 |
| End Date: | June 1, 2018 |
An Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)
This is a multi center open label study intended to provide photo documentation and time to
response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to
severe non-nodular inflammatory acne vulgarism.
response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to
severe non-nodular inflammatory acne vulgarism.
Inclusion Criteria:
- moderate to severe inflammatory non-nodular acne vulgaris
Exclusion Criteria:
- female subject who is breastfeeding, pregnant or planning a pregnancy during the study
- have other skin condition or disease that would interfere with the study
- have had any prior treatment with minocycline
- have a known or suspected allergy to tetracycline class products
- have used OTC medications for the treatment of facial acne within the last 14 days
- have used any prescription topical or oral medications for the treatment of facial
acne in the last 28 days
- have had a facial procedure (chemical peel, dermabrasion, laser, etc) within the last
8 weeks
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials